4//SEC Filing
Boenisch Sandra 4
Accession 0001731122-20-000024
CIK 0001314052other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:00 PM ET
Size
5.4 KB
Accession
0001731122-20-000024
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-06+70,000→ 70,000 totalExercise: $2.96Exp: 2030-01-06→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The options shall vest upon the achievement of a certain clinical trial milestone with respect to the Issuer's Phase 2 clinical trial program of Anavex(R)2-73 for the treatment of Rett syndrome.
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001655366
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 6:00 PM ET
- Size
- 5.4 KB